Researchers find people living with diabetes and related chronic kidney disease have better long-term outcomes on GLP1-RA therapies.

A new £1.2 million research project is underway to refine the benefits of weight-loss drugs while minimising their side effects. Led by experts at University College London (UCL) and the Rowett Institute at the University of Aberdeen, the study aims to improve the effectiveness of medications like semaglutide, widely known by its brand names Wegovy and Ozempic.

A new study from Sweden has found that severe obesity in childhood and adolescence more than triples the risk of developing Multiple Sclerosis (MS) later in life, even when lifestyle changes are implemented to reduce body fat.

A new systematic review has found that weight loss interventions, including behavioural programmes and pharmacotherapy, may improve symptoms of disordered eating in individuals with overweight or obesity.

Researchers have created a new map of a key part of our brain, the hypothalamus, that will lead to new ways of controlling our weight, appetite, sleep and stress levels.

A new Canadian study has found that toddlers who consume high amounts of ultra-processed foods (UPFs) are nearly 20 per cent more likely to be living with overweight or obese by the age of five.

Healthcare professionals, industry leaders, and service providers are invited to attend the Obesity Pathway Innovation Webinar on 13 February 2025 at 10am, hosted by Innovate UK.

Weight loss surgery can prevent people with obesity and fatty liver-related cirrhosis from developing major complications of liver disease, a new study has demonstrated.

A new study published in BMC Geriatrics has shed light on the "obesity paradox" in osteoporosis risk, revealing significant gender differences among older adults.

A new study led by researchers at the University of California, Riverside (UCR), is exploring the surprising link between obesity, parasitic infections, and the immune system, with a focus on gender-specific responses.

The rising popularity and accessibility of fast food takeaways are contributing to childhood obesity, and councils are urging central government for more support to address the crisis.

The first comprehensive study examining how weight-loss drugs impact overall health has revealed surprising benefits, and some potential risks, according to research involving two million participants.

Adding calorie labels to menus and food products may encourage people to select and consume slightly fewer calories, according to new research.

Intermittent fasting can help people lose weight, latest evidence has unveiled.

Could insisting that kids “clean their plate” be contributing to the obesity crisis?

For decades, BMI (body mass index) has been the gold standard for diagnosing obesity, a simple calculation of height and weight used to estimate excess body fat. But what if this long-standing measure is doing more harm than good?

New research in the United State suggests that metformin could enhance outcomes for people living with overweight and obesity individuals with lung cancer.

Residents in West Northamptonshire are invited to “kickstart the New Year” by joining a free weight management programme this month.  

A new study reveals that endoscopic sleeve gastroplasty (ESG) as a standalone treatment offers significant and lasting benefits for individuals with obesity and related health conditions.

Semaglutide, a medication widely used for managing obesity and type 2 diabetes, has shown effects beyond weight loss and glucose control, according to new research published in Nature Medicine.